Taiwan Bio-Manufacturing Corp (TBMC, 臺灣生物醫藥製造), a government-initiated biotech company, on Friday staged its first public event in Taipei, during which it outlined its business model as being similar to that of contract chipmaker Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and highlighted its strategic alliance with a US technology-focused biomanufacturing company.
The company, co-established by the Industrial Technology Research Institute (ITRI) and the Development Center for Biotechnology (DCB) last year, on Friday announced a strategic alliance with National Resilience Inc from the US, which it said would give it access to the latter’s expertise in biologics, vaccines, nucleic acids, cell therapy and gene therapy.
TBMC was started following the government’s realization during COVID-19 that Taiwan needed to have its own pharmaceutical manufacturing capabilities, Minister of National Development Kung Ming-hsin (龔明鑫) told a news conference in Taipei.
Photo courtesy of Taiwan Bio-Manufacturing Corp
“It is both a health issue and a national security issue,” he said.
The pandemic put Taiwan’s inability to mass produce mRNA vaccines under the spotlight, TBMC chairman and acting CEO Michel Chu (瞿志豪) said.
“Then-vice president Chen Chien-jen (陳建仁) and then-vice premier Shen Jong-chin (沈榮津) initiated a plan to start a company that specializes in the contract manufacturing of biologics, but can also manufacture vaccines during a pandemic,” Chu said in a video played at the news conference that introduced the company.
Chu also told the audience that the company plans to make the most of Taiwan’s advantages — abundant biotech talent and an outstanding smart manufacturing industry — to catapult the country into becoming a global market for contract development and manufacturing organizations (CDMOs).
CDMOs are companies that provide pharmaceutical companies with outsourcing options for drug development and manufacturing to lower risks and capital investment in advanced manufacturing processes.
TBMC is thus not only similar to TSMC in name, but also in its strategy of specializing in advanced contract manufacturing, Chu said.
The establishment of TBMC is based on the “successful experience” of TSMC, he added.
TBMC, like TSMC in 1986, was partly funded by the government, first employed talent from the ITRI — and also the DCB in the case of TBMC — and used foreign technologies and innovations “to secure the trust of future clients,” Chu said.
TSMC’s foreign partner back then was Royal Philips Electronics NV — which transferred some of its semiconductor patents to TSMC — while TBMC works with National Resilience.
“There are very few CDMOs in the world that out-license,” Chu said. “Many companies around the world would love for TSMC to authorize its advanced manufacturing technologies to them, but TSMC would definitely not be willing to do so.”
The reason TBMC was able to strike a deal with National Resilience was not just its special Taiwan connection — Resilience vice chairman Patrick Yang (楊育民) is Taiwanese American — but also because Taiwan has the exceptional automated and smart manufacturing capabilities that large-molecule drugs increasingly require, Chu said.
Large-molecule drugs, also known as biologics, are made from living organisms, while small-molecule drugs, which make up most of the pharmaceutical drugs on the market, are chemically synthesized.
Minister of Economic Affairs Wang Mei-hua (王美花) added that Taiwan has an edge when comes to talent, its medical system and protection of intellectual property, but “as the pharmaceutical industry is a field where big companies gain the most by remaining large, international collaboration is crucial for Taiwan’s biotech industry.”
CDMO shows great potential for biologics in Asia, Wang said, adding that TBMC has established a lab in the Taipei Bioinnovation Park and that it aims to have a Good Manufacturing Practices-grade factory in the Hsinchu Biomedical Science Park within two years.
“We’re hoping TBMC will become another ‘sacred mountain that protects the nation’ [as TSMC is referred to among Taiwanese] in the decades to come,” the minister said.
SEMICONDUCTORS: The firm has already completed one fab, which is to begin mass producing 2-nanomater chips next year, while two others are under construction Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, plans to begin construction of its fourth and fifth wafer fabs in Kaohsiung next year, targeting the development of high-end processes. The two facilities — P4 and P5 — are part of TSMC’s production expansion program, which aims to build five fabs in Kaohsiung. TSMC facility division vice president Arthur Chuang (莊子壽) on Thursday said that the five facilities are expected to create 8,000 jobs. To respond to the fast-changing global semiconductor industry and escalating international competition, TSMC said it has to keep growing by expanding its production footprints. The P4 and P5
Printed circuit board (PCB) maker Global Brands Manufacture Ltd (精成科技) is to fully acquire Japanese peer Lincstech Co for about NT$8.4 billion (US$256.9 million) as the company aims to add high-end PCBs to its PC-centric product lineups. The company also expects the deal to help expand its manufacturing sites in Southeast Asia, as local firms diversify to mitigate geopolitical risks. “The acquisition will mean an important step for the company to further expand its presence in Southeast Asia and globally,” Global Brands Manufacture chief financial officer Weng Chia-yu (翁家玉) said at a news conference in Taipei yesterday. The company has set up manufacturing
DOWNFALL: The Singapore-based oil magnate Lim Oon Kuin was accused of hiding US$800 million in losses and leaving 20 banks with substantial liabilities Former tycoon Lim Oon Kuin (林恩強) has been declared bankrupt in Singapore, following the collapse of his oil trading empire. The name of the founder of Hin Leong Trading Pte Ltd (興隆貿易) and his children Lim Huey Ching (林慧清) and Lim Chee Meng (林志朋) were listed as having been issued a bankruptcy order on Dec. 19, the government gazette showed. The younger Lims were directors at the company. Leow Quek Shiong and Seah Roh Lin of BDO Advisory Pte Ltd are the trustees, according to the gazette. At its peak, Hin Leong traded a range of oil products, made lubricants and operated loading
The growing popularity of Chinese sport utility vehicles and pickup trucks has shaken up Mexico’s luxury car market, hitting sales of traditionally dominant brands such as Mercedes-Benz and BMW. Mexicans are increasingly switching from traditionally dominant sedans to Chinese vehicles due to a combination of comfort, technology and price, industry experts say. It is no small feat in a country home to factories of foreign brands such as Audi and BMW, and where until a few years ago imported Chinese cars were stigmatized, as in other parts of the world. The high-end segment of the market registered a sales drop
RSS